The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

Under the deal terms, Schrodinger will deploy its AI-powered physics-enhanced software platform to spur drug development and curb production costs for Novartis. SDGR is another Wall Street ...

These drugs often cost thousands of dollars per month and ... justify these high prices by citing extensive research and development (R&D) expenses. However, critics argue that drug pricing ...